AbbVie, Inc. (ABBV)
261.67
+1.68
(+0.65%)
USD |
NYSE |
Sep 02, 16:00
261.80
+0.13
(+0.05%)
After-Hours: 18:49
AbbVie Market Cap : 462.39B for Sept. 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 01, 2026 | 459.42B |
| August 31, 2026 | 453.11B |
| August 28, 2026 | 451.45B |
| August 27, 2026 | 456.17B |
| August 26, 2026 | 464.56B |
| August 25, 2026 | 469.67B |
| August 24, 2026 | 467.43B |
| August 21, 2026 | 468.20B |
| August 20, 2026 | 462.67B |
| August 19, 2026 | 469.99B |
| August 18, 2026 | 457.53B |
| August 17, 2026 | 442.35B |
| August 14, 2026 | 440.81B |
| August 13, 2026 | 443.22B |
| August 12, 2026 | 439.58B |
| August 11, 2026 | 441.93B |
| August 10, 2026 | 438.18B |
| August 07, 2026 | 434.77B |
| August 06, 2026 | 430.94B |
| August 05, 2026 | 435.05B |
| August 04, 2026 | 430.81B |
| August 03, 2026 | 433.11B |
| July 31, 2026 | 443.43B |
| July 30, 2026 | 454.86B |
| July 29, 2026 | 465.27B |
| Date | Value |
|---|---|
| July 28, 2026 | 465.00B |
| July 27, 2026 | 453.89B |
| July 24, 2026 | 458.22B |
| July 23, 2026 | 453.91B |
| July 22, 2026 | 447.51B |
| July 21, 2026 | 452.46B |
| July 20, 2026 | 447.65B |
| July 17, 2026 | 449.62B |
| July 16, 2026 | 449.44B |
| July 15, 2026 | 431.28B |
| July 14, 2026 | 432.46B |
| July 13, 2026 | 438.15B |
| July 10, 2026 | 438.29B |
| July 09, 2026 | 441.52B |
| July 08, 2026 | 446.52B |
| July 07, 2026 | 449.90B |
| July 06, 2026 | 450.09B |
| July 02, 2026 | 461.24B |
| July 01, 2026 | 443.56B |
| June 30, 2026 | 444.58B |
| June 29, 2026 | 449.30B |
| June 26, 2026 | 447.60B |
| June 25, 2026 | 429.56B |
| June 24, 2026 | 414.99B |
| June 23, 2026 | 414.76B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 32.89B |
| Gilead Sciences, Inc. | 185.67B |
| Regeneron Pharmaceuticals, Inc. | 88.13B |
| Amgen, Inc. | 239.38B |
| REGENXBIO, Inc. | 519.70M |
Market Cap Related Metrics
| PE Ratio | 73.99 |
| PS Ratio | 7.205 |
| PEG Ratio | 1.083 |
| Price to Free Cash Flow | 25.47 |
| Price | 261.67 |
| Earnings Yield | 1.35% |
| PEGY Ratio | 1.043 |
| Operating PE Ratio | 21.08 |
| Normalized PE Ratio | 32.50 |